Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2005
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261328 Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents
11/24/2005US20050261303 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261281 Pharmaceutical compounds
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261192 Novel polypeptide and its DNA
11/24/2005US20050261164 Remedy for urinary frequency and urinary incontinence
11/24/2005US20050261161 Stable crystals of pyrrole compound
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents
11/24/2005US20050260174 Systems and methods for treating patients with processed lipoaspirate cells
11/24/2005DE102004019413A1 Use of substances (e.g. nucleic acids, proteins and peptides), which restrain/reduce the expression and/or activity of protein kinase C-epsilon for the treatment/prevention of e.g. circulatory and vascular diseases
11/24/2005CA2507712A1 Pharmaceutical compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598349A1 Novel 2-pyridinecarboxamide derivatives
11/23/2005EP1598346A1 Process for producing acid adduct salt of polyacidic base compound
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
11/23/2005EP1598076A1 Interleukin 6 production inhibitor
11/23/2005EP1597587A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a)
11/23/2005EP1597233A1 Benzyl urea and thiourea derivatives useful as androgen antagonists
11/23/2005EP1596856A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/23/2005EP1596850A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
11/23/2005EP1596849A1 Controlled release pharmaceutical compositions of tamsulosin
11/23/2005EP1446015A4 Remodeling of tissues and organs
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP1200831B1 Modulating binding site on potassium channels used for screening
11/23/2005EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition
11/23/2005EP0770129B1 Zinc finger protein derivatives and methods therefor
11/23/2005EP0732934B1 Long-acting injection suspensions of an lhrh analogue and a process for their preparation
11/23/2005CN1701068A Novel compounds and their use
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1700923A Multi-substituted selective androgen receptor modulators and methods of use thereof
11/23/2005CN1700920A Phophylactic and therapeutic use of hydroxysteroids
11/23/2005CN1228065C Medication for chronic renal failure
11/22/2005US6967210 Multiple sclerosis, brain disorders, analgesics
11/22/2005US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108400A1 Pyridoquinazoline derivatives having heterobicyclic substituents
11/17/2005WO2005108399A1 Imidazopyridine compound
11/17/2005WO2005108389A1 Indole derivatives having piperidine rings
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256326 Process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
11/17/2005US20050256317 Reacting a 5-thio-D-aldohexopyranose derivative with a hydroxyaromatic compound in the presence of a phosphine and an azo reagent; Mitsunobu reaction conditions; useful as an sodium-dependent glucose transporter (SGLT2) inhibitor; beta-selective glycosylation
11/17/2005US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
11/17/2005US20050256311 Pyrimidine compounds
11/17/2005US20050256166 Nitrogen-containing compounds
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256141 Remedies for glomerular diseases
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256110 Cyanopyrroles
11/17/2005US20050256103 Indole derivative having piperidine ring
11/17/2005US20050256048 Selective androgen receptor modulators and methods for their identification, design and use
11/17/2005US20050255529 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/17/2005US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005DE10392697T5 Herstellung und Standardisierung von immunmodulierenden Peptid-verknüpften Glucanen mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor Preparation and standardization of immunomodulating peptide-linked glucans with detectable oral absorbability from Coriolus Versicolor
11/17/2005CA2566184A1 Imidazopyridine compound
11/17/2005CA2564634A1 Permeation enhancing compositions for anticholinergic agents
11/16/2005EP1595867A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
11/16/2005EP1594846A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
11/16/2005EP1594836A1 Hydroxy-tetrahydro-naphthalenylurea derivatives
11/16/2005EP1594519A2 Cytomodulating peptides for treating interstitial cystitis
11/16/2005EP1594517A2 Methods and compositions for the treatment of gastrointestinal disorders
11/16/2005EP1594516A1 Herbal compositions for prostate conditions
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1397129B1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/16/2005EP1379516B1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1222191B1 Benzodiazepin derivatives, the production and use thereof
11/16/2005EP1146035B1 Crystal polymorphism of aminoethylphenoxyacetic acid derivative
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005CN1697836A Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227261C Monocyclic compounds with four bifunctional residues having NK-2 antagonist action, its preparation, medicine compositions and uses
11/16/2005CN1227251C Carbamates derived from arylalkylamines
11/16/2005CN1227237C Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor
11/16/2005CN1227033C Method of treating cancer with anti-neurotrophin agents
11/15/2005US6965051 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964975 Isoxazole and thiazole compounds and use thereof as medicine
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/15/2005US6964962 A norepinephrine reuptake inhibitor or its salt and a neuroleptic agent
11/15/2005US6964961 Antiproliferative agents for mammals
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/15/2005US6964955 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
11/15/2005US6964953 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
11/15/2005US6964946 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
11/15/2005US6964853 Smad6 and uses thereof
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 562